Cleco – Cleco Corporate Holdings Llc Separation Agreement (February 22nd, 2017)
Your severance from employment is involuntary and is directly or indirectly on account of the consummation of the transactions contemplated under that certain Agreement and Plan of Merger dated October 17, 2014, by and between the Company and Como 1 L.P. and Como 3 Inc. Your severance is part of a series of individual terminations, all occurring on or after the time of the consummation of such transactions, and may be considered part of a single program or group under Federal law. The information below is employment data related to the employees of the decisional unit identified above, who may be affected by the single program. The first column lists the job classification of each employee in the decisional unit; the second column lists the total number of employees employed in each classification; the third column provides the age of each employee; the fourth and fifth columns list the number of employees severed by age and the number retained by age, respectively.
Cleco – SECTION HEADING PAGE Section 13.1. Registration of Notes 31 Section 13.2. Transfer and Exchange of Notes 31 Section 13.3. Replacement of Notes 32 SECTION 14. PAYMENTS ON NOTES 32 Section 14.1. Place of Payment 32 Section 14.2. Home Office Payment 32 Section 14.3. FATCA Information 33 SECTION 15. EXPENSES, ETC 33 Section 15.1. Transaction Expenses 33 Section 15.2. Certain Taxes 34 Section 15.3. Survival 34 SECTION 16. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT 34 SECTION 17. AMENDMENT AND WAIVER 35 Section 17.1. Requirements 35 Section 17.2. Solicitation of Holders of Notes 35 (December 21st, 2016)
The Company will authorize the issue and sale of (a) $130,000,000 aggregate principal amount of its 3.47% Senior Notes, Series A, due December 16, 2026 (the Series A Notes), and (b) $200,000,000 aggregate principal amount of its 3.57% Senior Notes, Series B, due December 16, 2028 (the Series B Notes; collectively with the Series A Notes, the Notes, such term to include any such notes as amended, restated or otherwise modified from time to time pursuant to Section 17 and any such notes issued in substitution therefor pursuant to Section 13). The Notes shall be substantially in the form set out in Exhibit 1-A, and 1-B, as appropriate. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a Schedule or an Exhibit are, unless otherwise specified, to a Schedule or an Exhibit or attached to this Agreement. References to Series of Note shall refer to the Series A Notes or Series B Notes, or all, as the context may require.